Search

Search Constraints

You searched for: Author/Creator Cook, Gordon

Search Results

3. Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. Issue 12 (December 2016)

7. Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy. (10th June 2020)

8. Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. Issue 2 (3rd February 2021)

9. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Issue 12 (December 2021)

10. Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response. (17th February 2022)